Navigation Links
23ème congrès européen sur l'Hypertension et la Protection Cardiovasculaire
Date:6/25/2013

233;pondre à la diversité des patients et des marchés, et optimiser les opportunités de croissance tout au long de la chaîne de valeur du médicament.

Pour de plus amples informations, cliquez sur : http://www.daiichisankyo.com

A propos de Daiichi Sankyo Europe

Daiichi Sankyo Europe, dont le siège se situe à Munich, possède des filiales dans 12 pays européens, ainsi qu'un site de fabrication mondial à Pfaffenhofen en Allemagne. Pour de plus amples informations, cliquez sur : http://www.daiichi-sankyo.eu

Références

1    Sharman, J. E. & Laurent, S. Central blood pressure in the management of hypertension: soon reaching the goal? J Hum Hypertens [Epub ahead of print], (2013).

2    Pini, R. et al. Central but not brachial blood pressure predicts cardiovascular events in an unselected geriatric population: the ICARe Dicomano Study. J Am Coll Cardiol 51, 2432-2439, (2008).

3    Vlachopoulos, C. et al. Prediction of cardiovascular events and all-cause mortality with central haemodynamics: a systematic review and meta-analysis. Eur Heart J 31, 1865-1871, (2010).

4    Agabiti-Rosei, E. et al. Central blood pressure measurements and antihypertensive therapy: a consensus document. Hypertension 50, 154-160, (2007).

5    Williams, B. et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 113, 1213-1225, (2006).

6    Dahlof, B. et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required
'/>"/>

SOURCE Daiichi Sankyo Europe GmbH
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Members of Congress, Cancer Experts Address Impact of Genetic Testing on Cancer
2. Experts Launch the Alliance for Fertility Preservation at the International Society for Fertility Preservations 2nd World Congress
3. Global Leaders in Advanced Biofuels Industry Urge Congressional Leaders to Extend Critical Tax Provisions
4. Nation Must Invest in Biomedical Research/Health Workforce, AAHC President Tells Congress
5. PharmAthene Presents Update on SparVax™ rPA Anthrax Vaccine Program at the 2012 World Vaccine Congress
6. Neuralstem CEO to Present at the World Stem Cells and Regenerative Medicine Congress in London
7. ETEX Corporation to present at the 9th World Biomaterial Congress
8. Discovery Labs to Present AFECTAIR® Data at European Congress on Pediatric and Neonatal Ventilation
9. PROLOR Biotech Announces Presentation of Data on Its Long-Acting Clotting Factors at World Federation of Hemophilia World Congress
10. The Legends that Contributed to Silicon Valleys Eminence Assemble for Frost & Sullivans Growth, Innovation and Leadership 2012 Congress
11. BIOCOM Announces Endorsement in 52nd Congressional District Race
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... , July 23, 2014 ... portfolio company of Trendlines Agtech , announced ... Israel,s leading agricultural thermoplastics ... Valentis,s technology combines nanocrystalline cellulose (NCC), ... waste, with additional nanoparticles to produce highly improved ...
(Date:7/23/2014)... - BioAmber Inc. (NYSE: BIOA ), ... that the underwriters of its common stock offering ... additional 420,000 shares of common stock at the ... underwriting discounts and commissions, in connection with its ... of common stock, bringing the expected net proceeds ...
(Date:7/23/2014)... July 23, 2014 Shire ... the global specialty biopharmaceutical company, and ArmaGen, a ... worldwide licensing and collaboration agreement for AGT-182, an ... treatment of both the central nervous system (CNS) ... (MPS II). This collaboration strengthens Shire,s rare disease ...
(Date:7/23/2014)... MENLO PARK, Calif. , July 23, 2014 /PRNewswire/ ... based investment firm, today announced the closing of Sofinnova ... $500 million and in excess of the initial fund ... on helping entrepreneurs build successful biotechnology companies. Consistent with ... companies with promising later stage clinical programs, along with ...
Breaking Biology Technology:Valentis Nanotech Signs MOU to Integrate Technology in Thermoplastics Production 2BioAmber announces exercise in full of underwriters' option in connection with previously priced follow-on offering 2BioAmber announces exercise in full of underwriters' option in connection with previously priced follow-on offering 3Shire Enters Strategic Licensing and Collaboration Agreement With ArmaGen 2Shire Enters Strategic Licensing and Collaboration Agreement With ArmaGen 3Shire Enters Strategic Licensing and Collaboration Agreement With ArmaGen 4Shire Enters Strategic Licensing and Collaboration Agreement With ArmaGen 5Sofinnova Raises $500 Million Biotech Venture Fund 2
... 13 leading industry speakers will present at CBI,s 2nd ... on November 14-15, 2011 in Philadelphia. Nearly 100 TMF professionals ... shift taking place in the clinical trials -- moving from ... the heart of a clinical trial, the TMF is re-examined ...
... SEATTLE, Oct. 26, 2011 Immune Design Corp. ... vaccines and immunotherapies for infectious disease, cancer and ... an early-stage research collaboration with Sanofi-Aventis to investigate ... technology, a toll–like receptor 4 (TLR-4) agonist, in ...
... from this smorgasbord of recent salmonella outbreaks in the ... in 2011 alone, and the list goes on, according ... But perhaps not for long, thanks to a promising ... salmonella bacteria before contaminated food or animals reach the ...
Cached Biology Technology:
(Date:7/22/2014)... that feature natural habitats and trees and not just ... according to a University of Colorado Boulder study. , ... also provide stress-reducing benefits for youth, according to a ... The study is one of the first of ... access to green settings and stress. , "Many schools ...
(Date:7/22/2014)... prevent their daughters from breeding, and kill their grandchildren ... desert creatures which live in groups with a dominant ... alpha female can flourish when it maintains the sole right ... life, also found in many animals such as ants and ... Dominant meerkats control breeding within their group through violence, by ...
(Date:7/22/2014)... the genus of planthopper known as Conosimus, which now ... discovered in the southern part of the Iberian Peninsula ... it appears in the open-access Journal of Insect ... species, Conosimus baenai , has been named after ... the taxonomy of Iberian Hemiptera. , Conosimus baenai ...
Breaking Biology News(10 mins):Natural-terrain schoolyards reduce children's stress, says Colorado University-Boulder study 2Natural-terrain schoolyards reduce children's stress, says Colorado University-Boulder study 3
... , This release is available in French ... researchers have discovered a novel molecular mechanism that prevents cancer. ... Molecular Cell , scientists from the Universit de Montral and ... SOCS1 molecule prevents the cancer-causing activity of cytokines, hormones that ...
... amount of weight by eating less and exercising more improved ... of Medicine in St. Louis. The results of this ... the Journal of the American College of Cardiology , ... measures of heart and vascular health. The improvements seen in ...
... from 190 nations are gathered at the two-week ... about 150 distinguished guests attended an ESA-hosted side ... Essential Climate Variables,. During the event, speakers ... observation satellites play in providing systematic global climate ...
Cached Biology News:Scientists identify natural anti-cancer defenses 2Moderate weight loss in obese people improves heart function 2Moderate weight loss in obese people improves heart function 3Space agencies join forces to systematically observe climate variables 2Space agencies join forces to systematically observe climate variables 3
... Recognizes Nabeta2. The epitope ... present in any other known ... expected to work on human ... highly conserved (17/19 residues). Reactivity ...
Chicken polyclonal to HAGH ( Abpromise for all tested applications). Antigen: Synthetic peptide, corresponding to N terminal amino acids 110-260 of Human HAGH. Entrez GeneID: 3029 Swiss ...
Mouse monoclonal [SPM325] to Xanthine Oxidase, prediluted ( Abpromise for all tested applications). Antigen: C terminal 358 amino acid fragment of human xanthine oxidase. Entrez Gene ID: 749...
... for DNA isolation. Designed to ... 96 well plate adapters from Mo ... entire plate length (max capacity is ... used for soil, microorganisms, animal tissue, ...
Biology Products: